DIO2 and liver disorder: As a result, our study demonstrated that rs225014 (DIO2), rs532446 (GADD45A), rs12031994 (AKT3), rs11119982 (ATF3), rs10865710 (PPARG) might contribute to the increased risk of liver disease progression in chronic hepatitis b carriers.